[Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology*; D004231:Diuresis / Q000187:drug effects; D004573:Electrolytes / Q000378:metabolism; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000150:complications* / Q000188:drug therapy; D009941:Organomercury Compounds / Q000627:therapeutic use; D011139:Polythiazide / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D004573:Electrolytes; D009941:Organomercury Compounds; D006852:Hydrochlorothiazide; D013148:Spironolactone; D011139:Polythiazide; D014223:Triamterene
Studiu clinic şi biochimic privind efectul terapeutic al diureticului triamteren în cirozele ascitogene.